Remarkable Response to Neoadjuvant Therapy with Methotrexate, Vinblastine, Adriamycin, and Cisplatin for Undifferentiated Bladder Carcinoma: A Case Report and Literature Review

We report a case of primary undifferentiated bladder carcinoma, which revealed a remarkable response to methotrexate, vinblastine, adriamycin, and cisplatin (MVAC) therapy. A 46-year-old Japanese woman presented at the hospital with the chief complaints of gross hematuria and pain during urination....

ver descrição completa

Detalhes bibliográficos

Principais autores:	Kenji Numahata, Senji Hoshi, Kiyotsugu Hoshi, Nobuhiro Yasuno, Maiko Kubo, Isoji Sasagawa, Shoichiro Ohta
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Karger Publishers 2014-11-01
coleção:	Case Reports in Oncology
Assuntos:	Undifferentiated bladder carcinoma Methotrexate, vinblastine, adriamycin, and cisplatin Neoadjuvant chemotherapy
Acesso em linha:	http://www.karger.com/Article/FullText/369004
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!